Evidence map›Paper›PMID 30911240›Full record

ArticleNoro psikiyatri arsivi2019

Association Between Inflammatory Markers and Cognitive Outcome in Patients with Acute Brain Dysfunction Due to Sepsis.

Günseli Orhun, Erdem Tüzün, Perihan Ergin Özcan, Canan Ulusoy, Elif Yildirim, Melike Küçükerden, Hakan Gürvit, Achmet Ali, Figen Esen

Abstract read
In one paragraph

Article in Noro psikiyatri arsivi, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Observational
  10. Review
  11. Sepsis and Cognitive Assessment.Journal of clinical medicine · 2021
    Review
  12. Review
  13. Article
  14. Article
  15. Frontiers in immunology · 2020
    Article
  16. Diagnosing acute brain dysfunction due to sepsis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Günseli OrhunDepartment of Anesthesiology and Reanimation, İstanbul University Faculty of Medicine, İstanbul, Turkey.
Erdem TüzünDepartment of Neuroscience, Aziz Sancar Experimental Medicine Research Institute, İstanbul University, İstanbul, Turkey.
Perihan Ergin ÖzcanDepartment of Anesthesiology and Reanimation, İstanbul University Faculty of Medicine, İstanbul, Turkey.
Canan UlusoyDepartment of Neuroscience, Aziz Sancar Experimental Medicine Research Institute, İstanbul University, İstanbul, Turkey.
Elif YildirimDepartment of Neurology, İstanbul University Faculty of Medicine, İstanbul, Turkey.
Melike KüçükerdenDepartment of Neuroscience, Aziz Sancar Experimental Medicine Research Institute, İstanbul University, İstanbul, Turkey.
Hakan GürvitDepartment of Neurology, İstanbul University Faculty of Medicine, İstanbul, Turkey.
Achmet AliDepartment of Anesthesiology and Reanimation, İstanbul University Faculty of Medicine, İstanbul, Turkey.
Figen EsenDepartment of Anesthesiology and Reanimation, İstanbul University Faculty of Medicine, İstanbul, Turkey.
Istanbul University · TRTürk Anesteziyoloji ve Reanimasyon Derneği · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSepsis-induced brain dysfunction (SIBD) has been neglected until recently due to the absence of specific clinical or biological markers. There is increasing evidence that sepsis may pose substantial risks for long term cognitive impairment.

methodsTo find out clinical and inflammatory factors associated with acute SIBD serum levels of cytokines, complement breakdown products and neurodegeneration markers were measured by ELISA in sera of 86 SIBD patients and 33 healthy controls. Association between these biological markers and cognitive test results was investigated.

resultsSIBD patients showed significantly increased IL-6, IL-8, IL-10 and C4 d levels and decreased TNF-α, IL-12, C5a and iC3b levels than healthy controls. No significant alteration was observed in neuronal loss and neurodegeneration marker [neuron specific enolase (NSE), amyloid β, tau] levels. Increased IL-1β, IL-6, IL-8, IL-10, TNF-α and decreased C4 d, C5a and iC3b levels were associated with septic shock, coma and mortality. Transient mild cognitive impairment was observed in 7 of 21 patients who underwent neuropsychological assessment. Cognitive dysfunction and neuronal loss were associated with increased duration of septic shock and delirium but not baseline serum levels of inflammation and neurodegeneration markers.

conclusionIncreased cytokine levels, decreased complement activity and increased neuronal loss are indicators of poor prognosis and adverse events in SIBD. Cognitive dysfunction and neuronal destruction in SIBD do not seem to be associated with systemic inflammation factors and Alzheimer disease-type neurodegeneration but rather with increased duration of neuronal dysfunction and enhanced exposure of the brain to sepsis-inducing pathogens.

Indexed as

amyloid betacomplementcytokineencephalopathyneurodegenerationsepsis

Identifiers

PMID30911240
PMCPMC6427072
OpenAlexW2807085865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.